Lung cancer
Conditions
Interventions
Case series:all the biopsied tumor tissue were used for single cell analysis
Sponsors
Shanghai Pulmonary Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients over 18 years old; 2. Patients with lung cancer confirmed by pathology (including histology or cytology); 3. ECoG PS: 0-2 points; 4. Patients with expected survival >=3 months; 5. The subjects voluntarily participated in the study, signed a written informed consent before the implementation of any test related process, with good compliance and follow-up cooperation.
Exclusion criteria
Exclusion criteria: 1. The diagnosis is not lung cancer; 2. Patients who are currently participating in the intervention clinical research treatment, or who have received other research drugs or research instruments within 4 weeks before the first administration; 3. In patients with congestive heart failure of class III-IV (New York Heart Association classification), poor control of clinically significant arrhythmias; 4. Patients with known mental illness or drug abuse that may affect compliance with the trial requirements; 5. Patients with known history of human immunodeficiency virus (HIV) infection (i.e. HIV 1 / 2 antibody positive), active tuberculosis; 6. The researchers think it is not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| immune tumor microenvironments analysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| association of tumor immune microenvironment with stage, differentiation, treatment outcome and survival; | — |
Countries
China
Contacts
Public ContactFengying Wu
Shanghai Pulmonary Hospital
Outcome results
None listed